Join
Live feed
·
INSIDERFilingvia Quantisnow
Cognition Therapeutics Inc. logo

Director Kreis Leslie W. was granted 34,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CGTX· Cognition Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CGTX (Cognition Therapeutics Inc.) and more on Quantisnow.

Director Kreis Leslie W. was granted 34,000 shares (SEC Form 4) | Quantisnow